| Lisa Schwartz, | |
|
3950 Turkeyfoot Rd, Erlanger, KY 41018-2840 | |
| (859) 647-6211 | |
| (859) 647-0486 |
| Full Name | Lisa Schwartz |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3950 Turkeyfoot Rd, Erlanger, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326642554 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 009188 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Schwartz, 277 Secretariat Ct, Crestview Hills, KY 41017-2292 Ph: (859) 466-6893 | Lisa Schwartz, 3950 Turkeyfoot Rd, Erlanger, KY 41018-2840 Ph: (859) 647-6211 |
News Archive
Gen-Probe Incorporated today announced that the US Food and Drug Administration (FDA) has granted an EUA (emergency use authorization) for its test, the Prodesse ProFlu-ST(TM), to be used in CLIA high complexity laboratories for the diagnosis of 2009 H1N1 influenza virus infection, aided by an algorithm that relies on seasonal influenza A/H1 virus and seasonal influenza A/H3 virus results, from a single sample in individuals who are diagnosed with influenza A by currently available FDA-cleared or authorized devices.
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center found shortening a traditional 45-day course of radiation to a five-day course delivered in larger doses is safe and as effective as conventional radiation for men with high-risk forms of prostate cancer.
Genelabs Technologies today announced that a non-nucleoside compound from its internal Hepatitis C virus (HCV) drug discovery program has advanced into preclinical development.
Covidien plc today announced that its wholly-owned subsidiary, Covidien International Finance S.A. , priced an offering of $500 million aggregate principal amount of 1.875% senior notes due 2013, $400 million aggregate principal amount of 2.80% senior notes due 2015 and $600 million aggregate principal amount of 4.20% senior notes due 2020. The offering is expected to close on June 28, 2010.
The world's leading experts in pediatric pharmacogenomics and personalized medicine are gathering at a first-of-its-kind conference in Kansas City to change the way childhood diseases and illnesses are treated through personalized medicine.
› Verified 1 days ago
Crystal Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3158 Dixie Hwy, Erlanger, KY 41018 Phone: 859-344-0434 | |
Mr. Michael G Schepman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3126 Dixie Hwy, Erlanger, KY 41018 Phone: 859-331-5400 Fax: 859-331-0342 | |
Reece Jackson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1360 Dolwick Dr, Erlanger, KY 41018 Phone: 859-344-5555 Fax: 859-344-5552 | |
Hannah Gabrielle Sroka, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1360 Dolwick Drive, Erlanger, KY 41018 Phone: 859-344-5555 Fax: 859-344-5552 | |
Kelsey Ann Marie Villwock Hamilton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1360 Dolwick Drive, Erlanger, KY 41018 Phone: 859-344-5555 Fax: 859-344-5552 | |
Jameela Aladimi, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1360 Dolwick Drive, Erlanger, KY 41018 Phone: 859-344-5555 Fax: 859-344-5552 | |
Jamie Otte, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3158 Dixie Hwy, Erlanger, KY 41018 Phone: 859-344-0434 Fax: 859-344-1658 |